Delivery Order SPE2DB20D3101-SPE2DB24FRVT1
Award Date
9/21/24
Potential Completion Date
10/11/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CABOMETYX 40 MG TABLET 30S. The $61,386.20 firm fixed-price delivery order contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $30,693.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D2206|SPE2DB25FGQ86) for the medication Cabometyx 40 mg tablet, with a completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00...
This federal contract award, valued at $14,388.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a prescription medication, to support federal healthcare programs. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with an ultimate completion date of December 12, 2024. It is not designated as a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $28,777.92, is for the delivery of Cabometyx 60 mg tablets (30 count) under a firm fixed-price Delivery Order contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors in the world, is for the delivery of CABOMETYX 20 MG TABLET 30S to the Defense Logistics Agency (DLA). The $14,035.64 firm fixed-price delivery order has an ultimate completion date of August 1, 2024. The contract is not set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award, valued at $46,039.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $13,867.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $28,692.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of January 23, 2025 and is structured as a firm fixed-price delivery order. There is no set-aside designation indicated...
This federal contract award, valued at $15,346.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $14,388.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 31, 2024. The contract covers the procurement of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract...